Skip to main content
search
Tag

Ebola

Investigation of a rare Ebola relapse case in Central Africa Publication

Investigation of a rare Ebola relapse case in Central Africa

A CViSB collaboration recently published their findings on an important Ebola relapse case in the Democratic Republic of Congo. A 25-year-old man who had been vaccinated against Ebola in December of 2018 fell ill with the disease six months later. He received experimental treatments for Ebola and was released from the hospital on June 29th, 2019. Unfortunately, the illness returned…
Michelle McGraw
May 6, 2021
NIAID funds new partner center creidAwardsPress Release

NIAID funds new partner center

The ongoing COVID-19 pandemic has exposed the urgent need to protect the world from microbial threats, whenever and wherever they emerge. With a new $8.9 million grant, several CViSB investigators are partnering with peers in the United States and West Africa, a region of the world where infectious diseases are a high burden on public health. Together, we will seek…
Kristian Andersen
August 27, 2020
Ebola study w. VIC consortium vic_abstract_cellPublication

Ebola study w. VIC consortium

In two papers published in Cell and Cell Host Microbe CViSB investigators, together with colleagues from our VIC sister consortium, describe in detail antibody responses to Ebola. By systematic analysis of a large set of more than 170 monoclonal antibodies to Ebola virus, the researchers show which immunological features play key roles in protection against the virus. The researchers aimed to…
Kristian Andersen
August 9, 2018
Close Menu